ADMT (ADM Tronics Unlimited) Debt-to-EBITDA : -1.17 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ADM Tronics Unlimited Debt-to-EBITDA?

ADM Tronics Unlimited ADMT -2.50% Debt-to-EBITDA is -1.17 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 467 Medical Devices & Instruments companies, ADM Tronics Unlimited ranks worse than 96.15% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

ADM Tronics Unlimited's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $0.61 Mil. ADM Tronics Unlimited's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was $0.13 Mil. ADM Tronics Unlimited's annualized EBITDA for the quarter that ended in Mar. 2026 was $-0.64 Mil. ADM Tronics Unlimited's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was -1.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for ADM Tronics Unlimited's Debt-to-EBITDA or its related term are showing as below:

ADMT' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -9.56   Med: -0.31   Max: 70.58
Current: 20.58

During the past 13 years, the highest Debt-to-EBITDA Ratio of ADM Tronics Unlimited was 70.58. The lowest was -9.56. And the median was -0.31.

ADMT's Debt-to-EBITDA is ranked worse than
96.15% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 1.57 vs ADMT: 20.58

ADM Tronics Unlimited  (OTCPK:ADMT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


ADM Tronics Unlimited Debt-to-EBITDA Related Terms


ADM Tronics Unlimited Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for ADM Tronics Unlimited's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADM Tronics Unlimited Debt-to-EBITDA Chart

ADM Tronics Unlimited Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.13 9.40 -1.21 70.58 20.03

ADM Tronics Unlimited Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.21 0.53 -2.23 -2.28 -1.17

ADMT vs RMSL, USAQ, IVF: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, ADM Tronics Unlimited's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADM Tronics Unlimited Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ADM Tronics Unlimited's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ADM Tronics Unlimited's Debt-to-EBITDA falls into.



ADM Tronics Unlimited Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

ADM Tronics Unlimited's Debt-to-EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.611 + 0.13) / 0.037
=20.03

ADM Tronics Unlimited's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.611 + 0.13) / -0.636
=-1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -1.17 mean?
ADM Tronics Unlimited (ADMT) has a Debt-to-EBITDA of -1.17 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on ADM Tronics Unlimited. According to the industry distribution chart, ADM Tronics Unlimited ranks #449 out of 467 companies in the Medical Devices & Instruments industry, placing it in the top 96.1%.
Is ADM Tronics Unlimited's Debt-to-EBITDA too high?
ADM Tronics Unlimited's current Debt-to-EBITDA is -1.17. Based on the distribution chart, ADM Tronics Unlimited ranks #449 out of 467 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does ADM Tronics Unlimited's Debt-to-EBITDA compare to RMSL and USAQ?
According to the Medical Devices & Instruments industry distribution chart, ADM Tronics Unlimited ranks #449 out of 467 companies for Debt-to-EBITDA. This places ADM Tronics Unlimited in the lower half of its industry. The industry median Debt-to-EBITDA is 1.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.57, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on ADM Tronics Unlimited. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ADM Tronics Unlimited's current Debt-to-EBITDA is -1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADM Tronics Unlimited stock overvalued right now?
Based on GuruFocus' analysis, ADM Tronics Unlimited (ADMT) is currently considered Possible Value Trap. The stock's GF Value™ is $0.09, compared to a current price of $0.04 — trading 56.7% below its estimated fair value. The current Debt-to-EBITDA is -1.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For ADM Tronics Unlimited (ADMT), the current Debt-to-EBITDA is -1.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ADM Tronics Unlimited Business Description

Address 224 Pegasus Avenue, Northvale, NJ, USA, 07647
ADM Tronics Unlimited Inc is a diversified, technology-based developer and manufacturer of technologies and products in the United States. The company's operating segments include Chemical, Electronics, and Engineering. It generates maximum revenue from the Electronics segment. The Electronics segment develops and manufactures electronic technologies for non-invasive, electrotherapeutic, and diagnostic medical devices as well as for veterinary and other applications. It derives revenue from the production and sale of electronics for medical devices and other applications, as well as environmentally safe chemical products for industrial, medical, and cosmetic uses. Additionally, it offers research, development, regulatory, and engineering services.